Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Youngeun Ha"'
Autor:
Mi Young Cha, Youngeun Ha, Bu-Nam Jeon, Hyunuk Kim, Yunyeon Kim, Jiyeong Lee, Han-Sol Kim, A-Reum Jeong, Hyunkyung Yu, Kyung Mi Park, Hansoo Park
Publikováno v:
Cancer Research. 83:2968-2968
Immunotherapeutic treatment has profoundly improved the clinical outcomes in patients with advanced cancers. However, most patients still have not responded to immune checkpoint inhibitor (ICI) treatment. Thus, it is still urgent to find novel treatm
Autor:
Hyunkyung Yu, Nathalie Bellocq, Youngeun Ha, Hyunuk Kim, Yunyeon Kim, Bu-Nam Jeon, Léo Marx, Mathilde Pantin, Hyunjin Yoo, Seungmin Byun, Joo-Yeon Chung, Mi Young Cha, Patrick Garrouste, Frédéric Lévy
Publikováno v:
Cancer Research. 82:1760-1760
Antibody-drug conjugates (ADCs) are considered as promising cancer treatment modalities that combine the selectivity of antibodies and the cytotoxic properties of payloads using chemical linkers. However, despite their success, ADCs still suffer from
Autor:
Mi Young Cha, Hnkyung yu, Bu-Nam Jeon, Hyunuk Kim, Youngeun Ha, Yunyeon Kim, Joo-Yeon Chung, Soojung Moon, Hyunseong Youn, Han-sol Kim, Kyung Mi Park, Hansoo Park
Publikováno v:
Cancer Research. 82:2862-2862
The immunotherapeutic treatment has profoundly improved the clinical outcomes in patients with advanced cancers. However, most patients still have not responded to immune checkpoint inhibitor (ICI) treatment. Thus, it is still urgent to find novel tr
Autor:
Seung-Hyun Jung, Jahoon Kang, Youngeun Ha, Hyun-Kyung Yu, Ho Jeong Lee, Young Hoon Kim, Jae-Ho Lee, KweeHyun Suh, Eun Young Kim, Taehun Song, Hyo-Jeong Bang, Sun Jin Kim, Sun Young Lim, Moonsub Lee, Tae Woo Kim, Hyunjeong Kang, Young-Gil Ahn, Kyounghwa Koo, Joo-Yun Byun
Publikováno v:
Cancer Research. 78:4780-4780
Introduction: Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer and the second most frequent cause of cancer-related death, however, treatment options are very limited. In recent studies, aberrant signaling through FGFR4 and its ligan
Publikováno v:
Bulletin of the Korean Chemical Society. 33:1983-1988
Stem cell transplantation is emerging as a possible new treatment for liver cirrhosis, and recent animal studies have documented the benefits of stem cell therapy in a hepatic fibrosis model. However, the underlying mechanism of stem cell therapy is